tetradecanoylphorbol acetate has been researched along with ginsenoside rh1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, EA; Kim, DH; Kim, SS; Lee, BY; Lee, YC; Shin, YW | 1 |
| Choi, YJ; Lee, SG; Yoon, JH | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and ginsenoside rh1
| Article | Year |
|---|---|
The effects of ginsenoside Re and its metabolite, ginsenoside Rh1, on 12-O-tetradecanoylphorbol 13-acetate- and oxazolone-induced mouse dermatitis models.
Topics: Administration, Cutaneous; Animals; Dermatitis; Disease Models, Animal; Dose-Response Relationship, Drug; Ginsenosides; Keratolytic Agents; Mice; Mice, Inbred ICR; Oxazolone; Panax; Phytotherapy; Plant Roots; Tetradecanoylphorbol Acetate | 2006 |
Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells.
Topics: Anthracenes; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Flavonoids; Ginsenosides; Hep G2 Cells; Humans; Matrix Metalloproteinase 1; Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Signal Transduction; Tetradecanoylphorbol Acetate; Time Factors; Transcription Factor AP-1 | 2012 |